Evidence map›Paper›PMID 32473077›Full record

ArticleCancer science2020

Highly expressed tumoral emmprin and stromal CD73 predict a poor prognosis for external auditory canal carcinoma.

Masaru Miyazaki, Mikiko Aoki, Yasuko Okado, Kaori Koga, Makoto Hamasaki, Takashi Nakagawa, Toshifumi Sakata, Kazuki Nabeshima

Open access · goldAbstract read
In one paragraph

Article in Cancer science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. [Current status of the diagnosis and treatment of temporal bone squamous cell carcinoma].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2022
    Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Masaru MiyazakiDepartment of Pathology, Fukuoka University Hospital and School of Medicine, Fukuoka, Japan.
Mikiko AokiDepartment of Pathology, Fukuoka University Hospital and School of Medicine, Fukuoka, Japan.
Yasuko OkadoDepartment of Pathology, Fukuoka University Hospital and School of Medicine, Fukuoka, Japan.
Kaori KogaDepartment of Pathology, Fukuoka University Hospital and School of Medicine, Fukuoka, Japan.
Makoto HamasakiDepartment of Pathology, Fukuoka University Hospital and School of Medicine, Fukuoka, Japan.
Takashi NakagawaDepartment of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Toshifumi SakataDepartment of Otorhinolaryngology, Fukuoka University Hospital and School of Medicine, Fukuoka, Japan.
Kazuki NabeshimaDepartment of Pathology, Fukuoka University Hospital and School of Medicine, Fukuoka, Japan.ORCID https://orcid.org/0000-0002-0691-1222
Fukuoka University Hospital · JPKyushu University · JP

Funding

Research Center for Advanced Molecular Medicine, Fukuoka University
6 · The paper itself

Abstract

Squamous cell carcinoma of the external auditory canal (SCC-EAC) is rare and has a poor prognosis. The SCC-EAC cases with high-grade tumor budding (TB) or poorly differentiated clusters (PDCs) are associated with shorter survival than those with low-grade TB or PDCs. Extracellular matrix metalloproteinase inducer (emmprin) is a protein expressed in tumor cells that stimulates the production of MMP-2 by stromal fibroblasts to facilitate tumor invasion. Recently, we reported that emmprin forms a complex with CD73 to regulate MMP-2 production from fibroblasts in vitro. Here, we examined the association of emmprin and CD73 expression with TB or PDCs as well as with survival in 34 biopsy specimens of SCC-EAC patients. High tumoral emmprin expression was associated with high-grade TB, whereas high stromal CD73 expression was associated with high-grade PDCs. Furthermore, concurrent elevated expression of tumoral emmprin and stromal CD73 was determined to be an independent poor prognostic factor. In immunoprecipitation analyses, complex formation between emmprin and CD73 was demonstrated in vitro. Production of MMP-2 from fibroblasts was more abundant when cocultured with tumor cells than from fibroblasts cultured alone. Furthermore, MMP-2 production was reduced by the transfection of CD73 siRNA in fibroblasts cocultured with tumor cells. The colocalization of emmprin and CD73 was enhanced in not only the peripheral cells of the tumor cell clusters that interact with fibroblasts but also in the cells of intratumor clusters. Overall, this study provides novel insights into the roles of emmprin, CD73, and MMP-2 in tumor invasiveness.

Indexed as

5'-NucleotidaseAdultAgedAged, 80 and overBasiginBiomarkers, TumorBiopsyCancer-Associated FibroblastsCarcinoma, Squamous CellCell Line, TumorCoculture TechniquesDisease-Free SurvivalEar CanalEar NeoplasmsFemaleFollow-Up Studies5'-NucleotidaseBasiginBiomarkers, TumorBSG protein, humanGPI-Linked ProteinsMatrix Metalloproteinase 2MMP2 protein, humanNT5E protein, humanRNA, Small InterferingCD73emmprinexternal auditory canal carcinomapoorly differentiated clustertumor budding

Identifiers

PMID32473077
PMCPMC7419056
OpenAlexW3030685434

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.